These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Effects of continued NO inhibition on portal hypertensive syndrome after portal vein stenosis in rat. García-Pagán JC, Fernández M, Bernadich C, Pizcueta P, Piqué JM, Bosch J, Rodés J. Am J Physiol; 1994 Dec; 267(6 Pt 1):G984-90. PubMed ID: 7810666 [Abstract] [Full Text] [Related]
26. NAD(P)H oxidase modulates angiogenesis and the development of portosystemic collaterals and splanchnic hyperaemia in portal hypertensive rats. Angermayr B, Fernandez M, Mejias M, Gracia-Sancho J, Garcia-Pagan JC, Bosch J. Gut; 2007 Apr; 56(4):560-4. PubMed ID: 16854998 [Abstract] [Full Text] [Related]
27. A selective cyclo-oxygenase-2 inhibitor, NS-398, may improve portal hypertension without inducing gastric mucosal injury. Tsugawa K, Hashizume M, Migou S, Kishihara F, Kawanaka H, Tomikawa M, Sugimachi K. J Gastroenterol Hepatol; 1999 Jul; 14(7):642-51. PubMed ID: 10440208 [Abstract] [Full Text] [Related]
28. Cyclooxygenase inhibition reduces blood pressure elevation and vascular reactivity dysfunction caused by inhibition of nitric oxide synthase in rats. da Cunha V, Rossoni LV, Oliveira PA, Poton S, Pretti SC, Vassallo DV, Stefanon I. Clin Exp Hypertens; 2000 Feb; 22(2):203-15. PubMed ID: 10744360 [Abstract] [Full Text] [Related]
29. Haemodynamic and hormonal responses to long-term inhibition of nitric oxide synthesis in rats with portal hypertension. Pilette C, Moreau R, Sogni P, Kirstetter P, Cailmail S, Pussard E, Lebrec D. Eur J Pharmacol; 1996 Sep 19; 312(1):63-8. PubMed ID: 8891579 [Abstract] [Full Text] [Related]
33. Vasopressin reverses mesenteric hyperemia and vasoconstrictor hyporesponsiveness in anesthetized portal hypertensive rats. Heinemann A, Wachter CH, Fickert P, Trauner M, Stauber RE. Hepatology; 1998 Sep 19; 28(3):646-54. PubMed ID: 9731553 [Abstract] [Full Text] [Related]
34. The role of inducible nitric oxide synthase in vascular hyporeactivity of endotoxin-treated and portal hypertensive rats. Heinemann A, Stauber RE. Eur J Pharmacol; 1995 May 04; 278(1):87-90. PubMed ID: 7545125 [Abstract] [Full Text] [Related]
35. [Effects of nitric oxide and prostaglandin on gastric mucosal perfusion in rats with portal hypertensive gastropathy]. Le Q, Zhang J, Xu Q, Gao H. Zhonghua Gan Zang Bing Za Zhi; 2001 Aug 04; 9(4):232-4. PubMed ID: 11602057 [Abstract] [Full Text] [Related]
36. Vasopressin response and shunting modulation in cirrhotic rats by chronic nitric oxide inhibition. Huang HC, Wang SS, Lee FY, Chang CC, Chang FY, Lin HC, Hou MC, Lee SD. J Gastroenterol Hepatol; 2008 Jul 04; 23(7 Pt 2):e265-9. PubMed ID: 17764528 [Abstract] [Full Text] [Related]
37. Modifications produced by indomethacin and L-NAME in the effect of ultralow-dose aspirin on platelet activity in portal hypertension. Eizayaga FX, Aguejouf O, Desplat V, Belon P, Doutremepuich C. Pathophysiol Haemost Thromb; 2006 Jul 04; 35(5):357-63. PubMed ID: 17230036 [Abstract] [Full Text] [Related]